Introduction
The wide distribution of spirooxindole cores in numerous bioactive natural products and synthetic pharmaceutically relevant compounds stimulated a great deal of interest in the efficient construction and modification of this skeleton.
[1] In past decades, successful assemblies of spirooxindoles were realized through the elegant strategies including oxidative spirocyclization, [2] metal-mediated multi-step transformations, [3] Prins-type cyclization [4] and amino enyne catalysis. [5] However, the association of harsh conditions, tediousness of multi-step procedures and the involvement of metal catalyst with these protocols necessitate the development of new and facile approaches to this spirocyclic framework with biological significance. N-heterocyclic carbene (NHC) has been proven to be a powerful kind of catalysis for a variety of domino transformations to obtain heterocycles. [6] NHC-catalyzed reactions have been widely applied for organic chemistry, such as the benzoin condensation, [7] Stetter reaction, [8] a 3 -d 3 umpolung. [9] In recent years, as a crucial intermediate, NHCbounded vinyl enolate A has been converted from β,β-disubstituted enals, α,β-unsaturated esters, a,β-unsaturated acyl chlorides, α-bromo-α,β-unsaturated aldehydes successfully (Scheme 1). [10] Compared to these feedstocks, a,β-unsaturated carboxylic acids are more stable and accessible, which makes them ideal starting materials for NHC-catalyzed reactions. In 2014, Scheidt and co-workers reported the formation of azolium enolates from carboxylic acids and N,Ncarbonyldiimidazole (CDI) in the presence of NHCs. [11] Recently, Ye's group discovered an NHC-catalyzed generation of a,β-unsaturated acyl azoliums from α,β-unsaturated carboxylic acids via in situ generated mixed anhydrides for the synthesis of pyrrolidinone and dihydropyridinone derivatives (Scheme 2). [12] Scheme 1. Formation of NHC-bounded vinyl enolate.
Scheme 2. NHC-bounded intermediates generated through in situ activation of carboxylic acids.
More recently, our group have developed an NHC-catalyzed in situ activation strategy to β-functionalize the saturated carboxylic acids.
[13c] Thus we speculated that the combination of a,β-unsaturated carboxylic acids bearing γ-H with a condensing agent under the catalysis of NHCs could release the corresponding intermediates A and the subsequent annulation with isatins may provide a new access to spirocyclic oxindole-dihydropyranone The influences of chiral triazolium salts 4-7 were investigated to optimize the reaction conditions. As shown in table 2, 4b was the best precatalyst to give the desired cycloadduct 3a in 70% yield with 60% ee ( were tested to evaluate the scope of the base and only Cs 2 CO 3 was the most valid among the bases employed (Table 2 , entries 6-10). Compared to THF, ether, 1,4-dioxane and DCM, toluene was found to be optimal in 85% yield with 91% ee (Table 2 , entry 11 to 14). The screening of the temperature revealed that 0 o C afforded the best yield and enantioselctivity (92% ee). At the same time, lowering (-10 o C) or increasing (room temperature) the temperature had no positive effect on the reaction (Table 2 , entries 15 and 16). With the optimized reaction conditions in hand, the exploration of substrate scope was then briefly achieved. We observed that both electron-deficient (4-Br, 4-Cl, 4-F) and electron-rich (4-CH 3 , 4-MeO) moieties were tolerated well on the aryl group of the a,β-unsaturated acids 1. Furthermore, 2-Entry activator Yield(%) [a] ee(%) [b] 1 HATU 40 55
. Enantioselctivity determined by HPLC.
naphthyl substituted a,β-unsaturated carboxylic acid could also take part in this asymmetric protocol and delivered the corresponding product 3m in excellent yield. However, when the aryl group at 3-position of 1 was replaced with a Me group, the reaction gave the expected product in poor yield with moderate enantioselectivity. This should be attributed to the conjugation effect of aryl group. The different substituted groups (such as methyl, ethyl, allyl and benzyl) on the N-atom of isatin were also explored. We discovered that these desired cycloadducts were isolated in high yield with good enantioselectivity (Table  3 , entrys 1-3 and 12). Moreover, isatins with both electronwithdrawing groups (4-Br) and electron-donating group were well compatible with the reaction conditions. Product Yield(%) [a] ee(%) The absolute stereochemistry of (+)-3a was unambiguously established by the X-ray analysis of its crystal (Figure 1 ).
[15]
Other product configurations were deduced based on analogy (see the supporting information for details). A plausible catalytic cycle was illustrated in Scheme 4. The addition of NHC to α,β-unsaturated ester substrate, which was generated in situ from the α,β-unsaturated acid, formed the corresponding NHC-bounded intermediate B. B was deprotonated at γ-position to give the vinyl enolate C in the presence of base. The key intermediate C attacked the isatin 2 through a Diels-Alder reaction to give zwitterionic intermediate E. Moreover, the C=C bonds in intermediates B and C should adopt a E-configuration due to the steric effect, which made these intermediates more thermodynamically stable. Thus, a non-concerted nucleophilic addition with subsequent intramolecular cascade reaction of C and 2 could also generate intermediate E. 
Conclusions
In summary, we have developed an NHC-catalyzed in situ activation strategy to promote α,β-unsaturated carboxylic acid to involve a formal [4+2] annulation for the assembly of spirocyclic oxindole-dihydropyranone in good yields with up to 99% ee. Studies aimed at the expansion the reaction scope and the further development of analogous cyclization reactions of α,β-unsaturated carboxylic acid are underway in our lab.
Experimental
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(S)-4'-(4-bromophenyl)-5-methoxy-1-methylspiro[indoline-3,2'-pyran]-2,6'(3'H)-dione (3a

(S)-4'-(4-fluorophenyl)-5-methoxy-1-methylspiro[indoline-3,2'-pyran]-2,6'(3'H)-dione (3e),
(S)-1-ethyl-4'-(4-fluorophenyl)-5-methoxyspiro[indoline-3,2'-pyran]-2,6'(3'H)-dione (3f),
